The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Freeman Kevin D since year 2005.
The trader's CIK number is 1522478.
At the time of this reporting, Freeman Kevin D is the Director of Galectin Therapeutics Inc .
(stock ticker symbol GALT).
See this page for all insider trading activities at Galectin Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-07||GALT||Galectin Therapeutics Inc||Buy||8,400||1.63||13,725|
|2015-06-01||GALT||Galectin Therapeutics Inc||Buy||2,083||2.70||5,624|
|2014-08-15||GALT||Galectin Therapeutics Inc||Buy||1,000||4.70||4,700|
|2013-11-18||GALT||Galectin Therapeutics Inc||Buy||1,000||6.08||6,078|
|2013-05-28||GALT||Galectin Therapeutics Inc||Buy||1,000||4.21||4,212|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freeman Kevin D (Director of Galectin Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.